-
2
-
-
33847638137
-
Estimates of the cancer incidence and mortality in Europe in 2006
-
Ferlay J, Autier P, Boniol M, et al. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 2007;18(3):581-592
-
(2007)
Ann Oncol
, vol.18
, Issue.3
, pp. 581-592
-
-
Ferlay, J.1
Autier, P.2
Boniol, M.3
-
3
-
-
34247241630
-
The decrease in breast-cancer incidence in 2003 in the United States
-
Ravdin PM, Cronin KA, Howlader N, et al. The decrease in breast-cancer incidence in 2003 in the United States. N Engl J Med 2007;356(16):1670-1674
-
(2007)
N Engl J Med
, vol.356
, Issue.16
, pp. 1670-1674
-
-
Ravdin, P.M.1
Cronin, K.A.2
Howlader, N.3
-
4
-
-
19344364880
-
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: An overview of the randomised trials
-
EBCTCG EBCTCG
-
EBCTCG) EBCTCG. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005;365(9472):1687-1717
-
(2005)
Lancet
, vol.365
, Issue.9472
, pp. 1687-1717
-
-
-
5
-
-
33644895704
-
Community-based use of chemotherapy and hormonal therapy for early-stage breast cancer: 1987-2000
-
Harlan LC, Clegg LX, Abrams J, et al. Community-based use of chemotherapy and hormonal therapy for early-stage breast cancer: 1987-2000. J Clin Oncol 2006;24(6):872-877
-
(2006)
J Clin Oncol
, vol.24
, Issue.6
, pp. 872-877
-
-
Harlan, L.C.1
Clegg, L.X.2
Abrams, J.3
-
6
-
-
33747400905
-
Frequency and cost of chemotherapy-related serious adverse effects in a population sample of women with breast cancer
-
Hassett MJ, O'Malley AJ, Pakes JR, et al. Frequency and cost of chemotherapy-related serious adverse effects in a population sample of women with breast cancer. J Natl Cancer Inst 2006;98(16):1108-1117
-
(2006)
J Natl Cancer Inst
, vol.98
, Issue.16
, pp. 1108-1117
-
-
Hassett, M.J.1
O'Malley, A.J.2
Pakes, J.R.3
-
7
-
-
36849069347
-
American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer
-
Harris L. American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer. J Clin Oncol 2007;25:5287-5312
-
(2007)
J Clin Oncol
, vol.25
, pp. 5287-5312
-
-
Harris, L.1
-
8
-
-
0035865149
-
Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer
-
Ravdin PM, Siminoff LA, Davis GJ, et al. Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer. J Clin Oncol 2001;19(4):980-991
-
(2001)
J Clin Oncol
, vol.19
, Issue.4
, pp. 980-991
-
-
Ravdin, P.M.1
Siminoff, L.A.2
Davis, G.J.3
-
9
-
-
18444383684
-
Population-based validation of the prognostic model ADJUVANT! for early breast cancer
-
Olivotto IA, Bajdik CD, Ravdin PM, et al. Population-based validation of the prognostic model ADJUVANT! for early breast cancer. J Clin Oncol 2005;23(12):2716-2725
-
(2005)
J Clin Oncol
, vol.23
, Issue.12
, pp. 2716-2725
-
-
Olivotto, I.A.1
Bajdik, C.D.2
Ravdin, P.M.3
-
10
-
-
0035949684
-
Predicting the clinical status of human breast cancer by using gene expression profiles
-
West M, Blanchette C, Dressman H, et al. Predicting the clinical status of human breast cancer by using gene expression profiles. Proc Natl Acad Sci USA 2001;98(20):11462-11467
-
(2001)
Proc Natl Acad Sci USA
, vol.98
, Issue.20
, pp. 11462-11467
-
-
West, M.1
Blanchette, C.2
Dressman, H.3
-
11
-
-
19944422061
-
A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer
-
Paik S. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med 2004;351:2817-2826
-
(2004)
N Engl J Med
, vol.351
, pp. 2817-2826
-
-
Paik, S.1
-
12
-
-
0037478605
-
Repeated observation of breast tumor subtypes in independent gene expression data sets
-
Sorlie T. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci USA 2003;100:8418-8423
-
(2003)
Proc Natl Acad Sci USA
, vol.100
, pp. 8418-8423
-
-
Sorlie, T.1
-
13
-
-
33144462268
-
Gene expression profiling in breast cancer: Understanding the molecular basis of histologic grade to improve prognosis
-
Sotiriou C, Wirapati P, Loi S, et al. Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis. J Natl Cancer Inst 2006;98(4):262-272
-
(2006)
J Natl Cancer Inst
, vol.98
, Issue.4
, pp. 262-272
-
-
Sotiriou, C.1
Wirapati, P.2
Loi, S.3
-
14
-
-
18244409687
-
Gene expression profiling predicts clinical outcome of breast cancer
-
van't Veer LJ. Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002;415:530-536
-
(2002)
Nature
, vol.415
, pp. 530-536
-
-
Van't Veer, L.J.1
-
15
-
-
13844310310
-
Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer
-
Wang Y. Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 2005;365:671-679
-
(2005)
Lancet
, vol.365
, pp. 671-679
-
-
Wang, Y.1
-
16
-
-
0035072249
-
Expression profiling using microarrays fabricated by an ink-jet oligonucleotide synthesizer
-
Hughes TR, Mao M, Jones AR, et al. Expression profiling using microarrays fabricated by an ink-jet oligonucleotide synthesizer. Nat biotechnol 2001;19(4):342-347
-
(2001)
Nat Biotechnol
, vol.19
, Issue.4
, pp. 342-347
-
-
Hughes, T.R.1
Mao, M.2
Jones, A.R.3
-
17
-
-
0035884636
-
Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. Seventh International Conference on Adjuvant Therapy of Primary Breast Cancer
-
Goldhirsch A, Glick JH, Gelber RD, et al. Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. Seventh International Conference on Adjuvant Therapy of Primary Breast Cancer. J Clin Oncol 2001;19(18):3817-3827
-
(2001)
J Clin Oncol
, vol.19
, Issue.18
, pp. 3817-3827
-
-
Goldhirsch, A.1
Glick, J.H.2
Gelber, R.D.3
-
18
-
-
0035806484
-
National Institutes of Health Consensus Development Conference Statement: Adjuvant therapy for breast cancer, November 1-3, 2000
-
Eifel P, Axelson JA, Costa J, et al. National Institutes of Health Consensus Development Conference Statement: adjuvant therapy for breast cancer, November 1-3, 2000. J Natl Cancer Inst 2001;93(13):979-989
-
(2001)
J Natl Cancer Inst
, vol.93
, Issue.13
, pp. 979-989
-
-
Eifel, P.1
Axelson, J.A.2
Costa, J.3
-
19
-
-
33748693297
-
Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer
-
Buyse M, Loi S, van't Veer L, et al. Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer. J Natl Cancer Inst 2006;98(17):1183-1192
-
(2006)
J Natl Cancer Inst
, vol.98
, Issue.17
, pp. 1183-1192
-
-
Buyse, M.1
Loi, S.2
Van't Veer, L.3
-
20
-
-
0023203185
-
Confirmation of a prognostic index in primary breast cancer
-
Todd JH, Dowle C, Williams MR, et al. Confirmation of a prognostic index in primary breast cancer. Br J Cancer 1987;56(4):489-492
-
(1987)
Br J Cancer
, vol.56
, Issue.4
, pp. 489-492
-
-
Todd, J.H.1
Dowle, C.2
Williams, M.R.3
-
21
-
-
32244435355
-
Mechanisms of trastuzumab resistance and their clinical implications
-
Lan KH, Lu CH, Yu D. Mechanisms of trastuzumab resistance and their clinical implications. Ann NY Acad Sci 2005;1059:70-75
-
(2005)
Ann NY Acad Sci
, vol.1059
, pp. 70-75
-
-
Lan, K.H.1
Lu, Ch.2
Yu, D.3
-
22
-
-
36549011637
-
A new independent validation of the 70-gene signature in node-negative breast cancer
-
Bueno de Mesquita JM, Keijzer R, Linn SC, et al. A new independent validation of the 70-gene signature in node-negative breast cancer. Eur J Cancer Suppl 2006;4(2):131
-
(2006)
Eur J Cancer Suppl
, vol.4
, Issue.2
, pp. 131
-
-
Bueno De Mesquita, J.M.1
Keijzer, R.2
Linn, S.C.3
-
23
-
-
67649183386
-
The 70-gene prognosis-signature predicts disease outcome in breast cancer patients with 1-3 positive lymph nodes in an independent validation study
-
Epub Ahead of Print (doi: 10.1007/s10549-008-0130-2)
-
Mook S, Schmidt MK, Viale G, et al. The 70-gene prognosis-signature predicts disease outcome in breast cancer patients with 1-3 positive lymph nodes in an independent validation study. Breast Cancer Res Treat 2008. Epub Ahead of Print (doi: 10.1007/s10549-008-0130-2)
-
(2008)
Breast Cancer Res Treat
-
-
Mook, S.1
Schmidt, M.K.2
Viale, G.3
-
24
-
-
34547852275
-
Progress and promise: Highlights of the international expert consensus on the primary therapy of early breast cancer 2007
-
Goldhirsch A, Wood WC, Gelber RD, et al. Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007. Ann Oncol 2007;18(7):1133-1144
-
(2007)
Ann Oncol
, vol.18
, Issue.7
, pp. 1133-1144
-
-
Goldhirsch, A.1
Wood, W.C.2
Gelber, R.D.3
-
25
-
-
33751193656
-
Converting a breast cancer microarray signature into a high-throughput diagnostic test
-
Glas AM, Floore A, Delahaye LJ, et al. Converting a breast cancer microarray signature into a high-throughput diagnostic test. BMC Genomics 2006;7:278
-
(2006)
BMC Genomics
, vol.7
, pp. 278
-
-
Glas, A.M.1
Floore, A.2
Delahaye, L.J.3
-
26
-
-
34347395753
-
Robust interlaboratory reproducibility of a gene expression signature measurement consistent with the needs of a new generation of diagnostic tools
-
Ach RA, Floore A, Curry B, et al. Robust interlaboratory reproducibility of a gene expression signature measurement consistent with the needs of a new generation of diagnostic tools. BMC Genomics 2007;8:148
-
(2007)
BMC Genomics
, vol.8
, pp. 148
-
-
Ach, R.A.1
Floore, A.2
Curry, B.3
-
28
-
-
0037137519
-
A gene-expression signature as a predictor of survival in breast cancer
-
van de Vijver MJ. A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 2002;347:1999-2009
-
(2002)
N Engl J Med
, vol.347
, pp. 1999-2009
-
-
Van De Vijver, M.J.1
-
30
-
-
39149123547
-
Clinical application of the 70-gene profile: The MINDACT trial
-
Cardoso F, Van't Veer L, Rutgers E, et al. Clinical application of the 70-gene profile: the MINDACT trial. J Clin Oncol 2008;26(5):729-735
-
(2008)
J Clin Oncol
, vol.26
, Issue.5
, pp. 729-735
-
-
Cardoso, F.1
Van't Veer, L.2
Rutgers, E.3
-
31
-
-
33750601244
-
Gene signature evaluation as a prognostic tool: Challenges in the design of the MINDACT trial
-
Bogaerts J, Cardoso F, Buyse M, et al. Gene signature evaluation as a prognostic tool: challenges in the design of the MINDACT trial. Nat Clin Pract 2006;3(10):540-551
-
(2006)
Nat Clin Pract
, vol.3
, Issue.10
, pp. 540-551
-
-
Bogaerts, J.1
Cardoso, F.2
Buyse, M.3
-
32
-
-
34249311296
-
Individualization of therapy using MammaPrint: From development to the MINDACT Trial
-
Mook S. Individualization of therapy using MammaPrint: from development to the MINDACT Trial. Cancer Genomics Proteomics 2007;4:147-155
-
(2007)
Cancer Genomics Proteomics
, vol.4
, pp. 147-155
-
-
Mook, S.1
-
33
-
-
32944463609
-
Methods for gene expression profiling in clinical trials of adjuvant breast cancer therapy
-
Paik S. Methods for gene expression profiling in clinical trials of adjuvant breast cancer therapy. Clin Cancer Res 2006;12(3 Pt 2):1019s-23s
-
(2006)
Clin Cancer Res
, vol.12
, Issue.3 PART 2
-
-
Paik, S.1
-
34
-
-
33744808550
-
A population-based study of tumor gene expression and risk of breast cancer death among lymph node-negative patients
-
Habel LA, Shak S, Jacobs MK, et al. A population-based study of tumor gene expression and risk of breast cancer death among lymph node-negative patients. Breast Cancer Res 2006;8(3):R25
-
(2006)
Breast Cancer Res
, vol.8
, Issue.3
-
-
Habel, L.A.1
Shak, S.2
Jacobs, M.K.3
-
35
-
-
33744814477
-
Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer
-
Paik S, Tang G, Shak S, et al. Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer. J Clin Oncol 2006;24(23):3726-3734
-
(2006)
J Clin Oncol
, vol.24
, Issue.23
, pp. 3726-3734
-
-
Paik, S.1
Tang, G.2
Shak, S.3
-
36
-
-
51349107911
-
Comparison of prognostic gene expression signatures for breast cancer
-
Haibe-Kains B, Desmedt C, Piette F, et al. Comparison of prognostic gene expression signatures for breast cancer. BMC Genomics 2008;9:394
-
(2008)
BMC Genomics
, vol.9
, pp. 394
-
-
Haibe-Kains, B.1
Desmedt, C.2
Piette, F.3
-
37
-
-
2942578063
-
A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen
-
Ma XJ, Wang Z, Ryan PD, et al. A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen. Cancer Cell 2004;5(6):607-616
-
(2004)
Cancer Cell
, vol.5
, Issue.6
, pp. 607-616
-
-
Ma, X.J.1
Wang, Z.2
Ryan, P.D.3
-
38
-
-
33750598939
-
The HOXB13:IL17BR expression index is a prognostic factor in early-stage breast cancer
-
Ma XJ. The HOXB13:IL17BR expression index is a prognostic factor in early-stage breast cancer. J Clin Oncol 2006;24:4611-4619
-
(2006)
J Clin Oncol
, vol.24
, pp. 4611-4619
-
-
Ma, X.J.1
-
39
-
-
52049095087
-
A Five-Gene Molecular Grade Index and HOXB13:IL17BR are complementary prognostic factors in early stage breast cancer
-
Ma XJ, Salunga R, Dahiya S, et al. A Five-Gene Molecular Grade Index and HOXB13:IL17BR are complementary prognostic factors in early stage breast cancer. Clin Cancer Res 2008;14(9):2601-2608
-
(2008)
Clin Cancer Res
, vol.14
, Issue.9
, pp. 2601-2608
-
-
Ma, X.J.1
Salunga, R.2
Dahiya, S.3
-
40
-
-
51349088017
-
Biological processes associated with breast cancer clinical outcome depend on the molecular subtypes
-
Desmedt C, Haibe-Kains B, Wirapati P, et al. Biological processes associated with breast cancer clinical outcome depend on the molecular subtypes. Clin Cancer Res 2008;14(16):5158-5165
-
(2008)
Clin Cancer Res
, vol.14
, Issue.16
, pp. 5158-5165
-
-
Desmedt, C.1
Haibe-Kains, B.2
Wirapati, P.3
-
41
-
-
33746910265
-
Concordance among gene-expression-based predictors for breast cancer
-
Fan C. Concordance among gene-expression-based predictors for breast cancer. N Engl J Med 2006;355:560-569
-
(2006)
N Engl J Med
, vol.355
, pp. 560-569
-
-
Fan, C.1
-
42
-
-
70249137524
-
Combined use of genomic prognostic and treatment response predictors in breast cancer
-
abstract 527
-
Pusztai LH, Hatzis C, Cardoso F, et al. Combined use of genomic prognostic and treatment response predictors in breast cancer [abstract 527]. J Clin Oncol 2008;26(Suppl)
-
(2008)
J Clin Oncol
, vol.26
, Issue.SUPPL.
-
-
Pusztai, L.H.1
Hatzis, C.2
Cardoso, F.3
-
43
-
-
34250652449
-
Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series
-
Desmedt C. Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series. Clin Cancer Res 2007;13:3207-3214
-
(2007)
Clin Cancer Res
, vol.13
, pp. 3207-3214
-
-
Desmedt, C.1
-
44
-
-
0038488950
-
A multigenic program mediating breast cancer metastasis to bone
-
Kang Y, Siegel PM, Shu W, et al. A multigenic program mediating breast cancer metastasis to bone. Cancer cell 2003;3(6):537-549
-
(2003)
Cancer Cell
, vol.3
, Issue.6
, pp. 537-549
-
-
Kang, Y.1
Siegel, P.M.2
Shu, W.3
-
45
-
-
33744813556
-
Genes associated with breast cancer metastatic to bone
-
Smid M, Wang Y, Klijn JG, et al. Genes associated with breast cancer metastatic to bone. J Clin Oncol 2006;24(15):2261-2267
-
(2006)
J Clin Oncol
, vol.24
, Issue.15
, pp. 2261-2267
-
-
Smid, M.1
Wang, Y.2
Klijn, J.G.3
-
46
-
-
23144461051
-
Genes that mediate breast cancer metastasis to lung
-
Minn AJ, Gupta GP, Siegel PM, et al. Genes that mediate breast cancer metastasis to lung. Nature 2005;436(7050):518-524
-
(2005)
Nature
, vol.436
, Issue.7050
, pp. 518-524
-
-
Minn, A.J.1
Gupta, G.P.2
Siegel, P.M.3
-
47
-
-
68949149330
-
Gene expression analysis for prediction of early brain metastasis (BM) in HER2-positive (HER2+) breast cancer patients (pts)
-
abstract 1019
-
Duchnowska RJJ, Thorat MA, Morimiya A, et al. Gene expression analysis for prediction of early brain metastasis (BM) in HER2-positive (HER2+) breast cancer patients (pts) [abstract 1019]. J Clin Oncol 2008;26(Suppl)
-
(2008)
J Clin Oncol
, vol.26
, Issue.SUPPL.
-
-
Duchnowska, R.J.J.1
Thorat, Ma.2
Morimiya, A.3
-
48
-
-
0042125511
-
Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer
-
Chang JC, Wooten EC, Tsimelzon A, et al. Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer. Lancet 2003;362(9381):362-369
-
(2003)
Lancet
, vol.362
, Issue.9381
, pp. 362-369
-
-
Chang, J.C.1
Wooten, E.C.2
Tsimelzon, A.3
-
49
-
-
20044377912
-
Molecular classification of tamoxifen-resistant breast carcinomas by gene expression profiling
-
Jansen MPHM, Foekens JA, van Staveren IL, et al. Molecular classification of tamoxifen-resistant breast carcinomas by gene expression profiling. J Clin Oncol 2005;23(4):732-740
-
(2005)
J Clin Oncol
, vol.23
, Issue.4
, pp. 732-740
-
-
Mphm, J.1
Foekens, J.A.2
Van Staveren, I.L.3
-
50
-
-
59149101766
-
Identification of a 6 gene molecular predictor of lapatinib related benefit: From breast cancer cell lines to a phase III trial
-
abstract 1043
-
Gray JW, Das D, Wang N, et al. Identification of a 6 gene molecular predictor of lapatinib related benefit: From breast cancer cell lines to a phase III trial [abstract 1043]. J Clin Oncol 2008;(Suppl)
-
(2008)
J Clin Oncol
, Issue.SUPPL.
-
-
Gray, J.W.1
Das, D.2
Wang, N.3
-
52
-
-
71749117906
-
-
Available from: [cited 3 October 2008]
-
GenomicHealth. The Role of Oncotype DX. Available from: http://www.genomichealth.com/oncotype/role/default.aspx. 2008 [cited 3 October 2008]
-
(2008)
The Role of Oncotype DX
-
-
-
53
-
-
77953391810
-
-
Available from: [cited 3 October 2008]
-
Ipsogen. Improving the clinical value of tumor grading. Available from: http://www.ipsogen.com/breast-cancer-products/healthcare-professionnals/ mapquant-dxgenomicgrade/. 2008 [cited 3 October 2008]
-
(2008)
Improving the Clinical Value of Tumor Grading
-
-
|